QP
INSIDER · ORKA · Oruka Therapeutics, Inc. · GENERAL COUNSEL
Quinlan Paul T
Every open-market transaction filed under this name, Sep 15 to Oct 20.
Filings
10
0 buys · 10 sells
Bought
—
open market, at cost
Sold
$1.7M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 20 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 3,000 | $79.49 | $238K | +20.8% |
| Oct 20 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 4,100 | $78.79 | $323K | +21.9% |
| Oct 20 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 1,000 | $77.20 | $77K | +24.4% |
| Oct 20 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 500 | $76.12 | $38K | +26.1% |
| Oct 20 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 400 | $74.90 | $30K | +28.2% |
| Sep 21 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 2,667 | $95.31 | $254K | +0.7% |
| Sep 21 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 601 | $94.44 | $57K | +1.7% |
| Sep 21 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 3,832 | $93.32 | $358K | +2.9% |
| Sep 21 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 2,900 | $92.37 | $268K | +4.0% |
| Sep 15 | ORKA | Oruka Therapeutics, Inc. | General Counsel | Sell | 1,039 | $95.71 | $99K | +0.3% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.